Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > New vaxil video.

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Jan 14, 2021 10:07am

77 Views

Post# 32293342

RE:RE:RE:New vaxil video.

Ya they should be dating these videos.....now timelines are crazy

kevlin139 wrote:
was uploaded today. From the title 2020 recap, im guessing was made mid to late dec. just my opinion

bligicka wrote: When was that video recorded cause he says they hope to have results from Army in the next couple of months ???

kevlin139 wrote: https://youtu.be/yvhw4I3yytg